HF
APRE icon

HRT Financial’s Aprea Therapeutics APRE Stock Holding History

HRT Financial’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,264
Closed -$18K – 3136
2025
Q3 		$18K Buy
+12,264
New +$20.2K ﹤0.01% 2714
2021
Q3 		– Sell
-1,245
Closed -$121K – 3247
2021
Q2 		$121K Sell
1,245
-2,434
-66% -$225K ﹤0.01% 2546
2021
Q1 		$375K Buy
+3,679
New +$429K ﹤0.01% 1981

Other funds holding APRE

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's APRE Position: Q4 2025 in Review

HRT Financial sold out of Aprea Therapeutics (APRE) in Q4 2025, closing a stake of 12,264 shares — an estimated $18K sold.

HRT Financial first reported a position in APRE in Q1 2021 and held it in 3 quarters. The position peaked at $375K in Q1 2021. 22 funds tracked by Wall St. Rank hold APRE as of Q4 2025.

  • HRT Financial reported no remaining Aprea Therapeutics position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 12,264 Aprea Therapeutics shares in Q4 2025, an estimated $18K.
  • HRT Financial first reported a position in Aprea Therapeutics in Q1 2021 and held it in 3 quarters.
  • HRT Financial's Aprea Therapeutics position peaked at $375K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.